No benefits of hypothermia in patients treated with hemicraniectomy for large ischemic stroke. En savoir plus sur No benefits of hypothermia in patients treated with hemicraniectomy for large ischemic stroke.
Long-term outcomes of refractory neurosarcoidosis treated with infliximab. En savoir plus sur Long-term outcomes of refractory neurosarcoidosis treated with infliximab.
Expression of Yo Antigen in a Prostatic Adenocarcinoma. En savoir plus sur Expression of Yo Antigen in a Prostatic Adenocarcinoma.
Authors' reply - Clozapine for mitochondrial psychosis. En savoir plus sur Authors' reply - Clozapine for mitochondrial psychosis.
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. En savoir plus sur Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Autism spectrum disorder associated with 49,XYYYY: case report and review of the literature. En savoir plus sur Autism spectrum disorder associated with 49,XYYYY: case report and review of the literature.
ATXN2 trinucleotide repeat length correlates with risk of ALS. En savoir plus sur ATXN2 trinucleotide repeat length correlates with risk of ALS.
Low dose clozapine controls adult-onset psychosis associated with the neurogenic ataxia-retinitis pigmentosa (NARP) mutation. En savoir plus sur Low dose clozapine controls adult-onset psychosis associated with the neurogenic ataxia-retinitis pigmentosa (NARP) mutation.
Exchangeable copper: a reflection of the neurological severity in Wilson's disease. En savoir plus sur Exchangeable copper: a reflection of the neurological severity in Wilson's disease.
Early diaphragm pacing in patients with amyotrophic lateral sclerosis (RespiStimALS): a randomised controlled triple-blind trial. En savoir plus sur Early diaphragm pacing in patients with amyotrophic lateral sclerosis (RespiStimALS): a randomised controlled triple-blind trial.
